Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

February 2, 2016September 26, 2016

Dietary Management of Ulcerative Colitis, Gastroenterological Conditions Aided With New Probiotic

IBD News, News, Ulcerative colitis

ExeGi Pharma, based in Gaithersburg, Maryland, recently announced the launch of Visbiome and Visbiome Extra Strength, the company’s new probiotic formulations for the dietary management of gastroenterological conditions such as ulcerative colitis, ... Read more

February 1, 2016February 1, 2016

Advanced Dermatology Partners With Crohn’s & Colitis Foundation for Take Steps Program

Crohn's Disease, IBD News, News

Advanced Dermatology is collaborating with the Crohn’s & Colitis Foundation of America to raise funds and assist CCFA’s Take Steps walk program to support critical research and patient support for the 1.6 million Americans living ... Read more

January 28, 2016September 14, 2016

Gut Microbiota of Children May Be Adversely Affected by Antibiotics

News

Antibiotic use in early childhood interferes with normal development of the intestinal microbiota, according to researchers at the University of Helsinki, Finland, in the study “Intestinal microbiome is related to lifetime ... Read more

January 27, 2016May 17, 2016

Development of Drug for Ulcerative Colitis to Be Discontinued, Company Reports

News

Belgium-based Galapagos NV has announced it is discontinuing its clinical development of drug candidate GLPG1205 for ulcerative colitis because an important part of the clinical trial — endpoints for efficacy — were not met. The ... Read more

January 21, 2016January 21, 2016

For IBS Patients, Smart Gas Sensing Pills Yield Promising Early Results

News

The first-ever trial using smart pills that can measure intestinal gases inside a person’s body was recently conducted, yielding striking results that revealed previously unthought-of ways in which fiber affects the ... Read more

January 19, 2016January 19, 2016

Novel IBD Research into Disease Prevention Supported by $300k Grant

News

Benoit Chassaing, a Georgia State University researcher, recently received a $300,000 Career Development Award from the Crohn’s and Colitis Foundation of America to investigate how the immune system can prevent the ... Read more

January 18, 2016January 18, 2016

Potential Ulcerative Colitis Therapy Advancing in Clinical Development

News, Ulcerative colitis

Tiziana Life Sciences recently announced its plan for further development of foralumab, the company’s fully human anti-CD3 antibody, with a first evaluation of the compound in two clinical indications: graft vs. ... Read more

January 15, 2016January 15, 2016

IBD Patients to Benefit From SonarMD Partnership With Digestive Healthcare Center

News

Illinois-based SonarMD recently announced a collaboration with New Jersey’s Digestive Healthcare Center to improve care for patients with inflammatory bowel disease (IBD), including Crohn’s disease. Under the terms of the collaboration, ... Read more

January 14, 2016January 14, 2016

IBD Study Finds Chromoendoscopy Best at Detecting Cancerous Changes

News

In a new study, researchers reported that chromoendoscopy is a more effective diagnostic and monitoring method for detection of dysplasia in long-term surveillance of inflammatory bowel disease (IBD). The article, ... Read more

January 13, 2016January 13, 2016

IBD Patients Treated With Anti-TNF Drug Develop Skin Lesions

News

In a new study, researchers investigated the development of skin lesions and their clinical course in patients with inflammatory bowel disease (IBD) who were under anti-tumor necrosis factor (TNF) antibody ... Read more